Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVLS.L Regulatory News (VLS)

  • There is currently no data for VLS

Form 8 - Velocys PLC

24 Nov 2023 16:26

RNS Number : 6486U
Velocys PLC
24 November 2023
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Velocys PLC

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Velocys PLC

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

24 November 2023

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

Nil

Nil

Nil

(2) Cash-settled derivatives:

 

Nil

Nil

Nil

Nil

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

Nil

Nil

Nil

 

TOTAL:

Nil

Nil

Nil

Nil

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

Nil

Details, including nature of the rights concerned and relevant percentages:

Nil

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

(a) Interests held by directors of Velocys PLC and their close relatives:

 

Name

Number of ordinary shares

Percentage of the issued Shares

Henrik Wareborn

3,118,445

0.18%

Philip Sanderson

600,000

0.03%

Philip Holland

1,743,634

0.10%

Ann Markey

525,000

0.03%

Tom Quigley

525,000

0.03%

Darran Messem

558,333

0.03%

 

 

(b) Options held by directors of Velocys PLC:

 

Name

Description of share option scheme

Number of ordinary shares under option

Date of grant

Exercise period

Exercise price

Henrik Wareborn

Velocys Share Option Scheme 2012

2,000,000

13/12/2019

13/12/2019 to 12/12/2029

£0.10

Henrik Wareborn

Velocys Share Option Scheme 2012

6,250,000

13/12/2019

13/12/2022 to 12/12/2029

£0.03

Henrik Wareborn

Velocys Share Option Scheme 2012

3,264,504

9/02/2021

09/02/2024 to 08/02/2031

£0.0786

Henrik Wareborn

Velocys Share

Option Scheme 2021

2,343,750

13/01/ 2022

13/01/2025 to 12/01/2032

£0.08

Henrik Wareborn

Velocys Share

Option Scheme 2021

9,000,000

19/06/2023

19/06/2026 to 19/06/2028

£0.025

Philip Sanderson

Velocys Share

Option Scheme 2021

5,000,000

22/06/2022

22/06/2025 to 22/06/2032

£0.045

Philip Sanderson

Velocys Share

Option Scheme 2021

7,500,000

19/06/2023

19/06/2026 to 19/06/2028

£0.025

 

(c) Interests held by other persons presumed to be acting in concert with Velocys PLC:

 

None

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

24 November 2023

Contact name:

David Bate

Telephone number:

+44 1865 800821

 

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEUSANROBUAUAA
Date   Source Headline
6th Sep 201812:02 pmRNSPrice Monitoring Extension
6th Sep 201811:07 amRNSStatement re Share Price Movement
15th Aug 20182:40 pmRNSHolding(s) in Company
13th Aug 20185:00 pmRNSTR-1: Notification of major holdings
13th Aug 201810:10 amRNSHolding(s) in Company
8th Aug 201812:26 pmRNSResult of general meeting and total voting rights
7th Aug 20187:00 amRNSEnvironmental milestone for Mississippi project
23rd Jul 20187:05 amRNSFund raise of £6 million
4th Jul 20187:00 amRNSENVIA plant update
3rd Jul 20182:54 pmRNSBlock listing Interim Review
29th Jun 201812:52 pmRNSResult of AGM
19th Jun 20187:00 amRNSVelocys and PQ partner for catalyst manufacturing
18th Jun 20187:00 amRNSDevelopment funding secured for UK project
5th Jun 20182:53 pmRNSMailing of 2017 annual report and AGM notice
23rd May 20187:00 amRNSFinal results for the year ended 31 December 2017
15th May 20187:00 amRNSENVIA plant update
4th May 20187:00 amRNSVelocys sells license to Red Rock Biofuels
17th Apr 20187:01 amRNSResponse to press coverage
15th Mar 20187:00 amRNSENVIA biorefinery - RINs verified
26th Feb 20181:37 pmRNSHolding(s) in Company
7th Feb 20187:00 amRNSDirectorate Change
6th Feb 20187:00 amRNSHolding(s) in Company
6th Feb 20187:00 amRNSHolding(s) in Company
5th Feb 20187:00 amRNSHolding(s) in Company
5th Feb 20187:00 amRNSHolding(s) in Company
2nd Feb 201812:11 pmRNSDirector/PDMR Shareholding
31st Jan 20183:21 pmRNSResult of general meeting and total voting rights
16th Jan 20187:00 amRNSOklahoma City plant - RIN credit submission
15th Jan 20187:00 amRNSFund raise of approximately £18.4 million
3rd Jan 20185:20 pmRNSBlock listing Interim Review
1st Nov 201710:02 amRNSTotal Voting Rights
30th Oct 20177:00 amRNSOklahoma City plant on track for final capacity
20th Oct 20177:00 amRNSSite confirmed for first U.S. biorefinery
29th Sep 20177:00 amRNSInterim results for the 6 months ended 30 June 17
28th Sep 20179:49 amRNSChange of Registered Office
18th Sep 201710:00 amRNSPartnership formed, aimed at waste-to-jet-fuel
1st Aug 20179:37 amRNSTotal Voting Rights
21st Jul 20177:01 amRNSBusiness Update
21st Jul 20177:00 amRNSDirectorate Change
3rd Jul 20179:34 amRNSBlock listing Interim Review
30th Jun 20177:00 amRNSFirst finished product at ENVIA Energy's GTL plant
22nd Jun 20171:45 pmRNSResult of AGM
22nd Jun 20177:00 amRNSAGM Statement
19th Jun 20177:00 amRNSAdvancing towards U.S. Dept. of Agriculture Loan
16th Jun 20177:00 amRNSDirectorate Change
6th Jun 20171:29 pmRNSHolding(s) in Company
5th Jun 20177:00 amRNSSelection of IHI E&C for feasibility engineering
1st Jun 20173:14 pmRNSDirectorate Change
1st Jun 20171:58 pmRNSResult of General Meeting
26th May 201711:02 amRNSMailing of Annual Financial Report & AGM Notice

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.